Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE) Insider Trading
Directors, officers and holders of more than 10% of GLUE report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 127 transactions on file: 0 with code P, 17 with code S and 33 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Bowen Matthew | Principal Accounting Officer | S Sale | 13 | $10.56 | $137 |
| Jul 16, 2026 | Warmuth Markus | President & CEO | S Sale | 9,500 | $23.18 | $220,219 |
| Jul 15, 2026 | Champoux Jennifer | Chief Operating Officer | S Sale | 4,351 | $23.38 | $101,730 |
| Jul 15, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 4,351 | Not measured | Not measured |
| Jul 15, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 4,351 | $3.98 | $17,317 |
| Jul 6, 2026 | Townson Sharon | Chief Scientific Officer | S Sale | 5,600 | $23.25 | $130,197 |
| Jul 6, 2026 | Townson Sharon | Chief Scientific Officer | M Exercise | 6,000 | Not measured | Not measured |
| Jul 6, 2026 | Townson Sharon | Chief Scientific Officer | S Sale | 400 | $24.13 | $9,652 |
| Jul 6, 2026 | Townson Sharon | Chief Scientific Officer | M Exercise | 6,000 | $6.14 | $36,840 |
| Jul 1, 2026 | Behbahani Ali | Director | J Other | 1,000,000 | Not measured | Not measured |
| Jul 1, 2026 | Behbahani Ali | Director | J Other | 15,000 | Not measured | Not measured |
| Jul 1, 2026 | Behbahani Ali | Director | J Other | 15,000 | Not measured | Not measured |
| Jun 30, 2026 | Janku Filip | Chief Medical Officer | S Sale | 5,407 | $24.50 | $132,472 |
| Jun 30, 2026 | Janku Filip | Chief Medical Officer | M Exercise | 5,407 | Not measured | Not measured |
| Jun 30, 2026 | Janku Filip | Chief Medical Officer | M Exercise | 5,407 | $13.41 | $72,508 |
| Jun 24, 2026 | Janku Filip | Chief Medical Officer | S Sale | 30,000 | $21.42 | $642,681 |
| Jun 24, 2026 | Janku Filip | Chief Medical Officer | M Exercise | 30,000 | Not measured | Not measured |
| Jun 24, 2026 | Janku Filip | Chief Medical Officer | M Exercise | 30,000 | $7.56 | $226,800 |
| Jun 23, 2026 | Janku Filip | Chief Medical Officer | S Sale | 11,845 | $20.22 | $239,522 |
| Jun 23, 2026 | Champoux Jennifer | Chief Operating Officer | S Sale | 2,175 | $20.00 | $43,500 |
| Jun 23, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 2,175 | $3.98 | $8,657 |
| Jun 23, 2026 | Townson Sharon | Chief Scientific Officer | M Exercise | 3,000 | Not measured | Not measured |
| Jun 23, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 2,175 | Not measured | Not measured |
| Jun 23, 2026 | Townson Sharon | Chief Scientific Officer | S Sale | 3,000 | $20.00 | $60,000 |
| Jun 23, 2026 | Townson Sharon | Chief Scientific Officer | M Exercise | 3,000 | $6.14 | $18,420 |
| Jun 23, 2026 | Janku Filip | Chief Medical Officer | M Exercise | 6,000 | $7.56 | $45,360 |
| Jun 23, 2026 | Janku Filip | Chief Medical Officer | M Exercise | 6,000 | Not measured | Not measured |
| Jun 17, 2026 | Champoux Jennifer | Chief Operating Officer | S Sale | 2,176 | $19.00 | $41,344 |
| Jun 17, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 2,176 | $3.98 | $8,660 |
| Jun 17, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 2,176 | Not measured | Not measured |
| Jun 17, 2026 | Townson Sharon | Chief Scientific Officer | M Exercise | 3,000 | Not measured | Not measured |
| Jun 17, 2026 | Townson Sharon | Chief Scientific Officer | S Sale | 3,000 | $19.00 | $57,000 |
| Jun 17, 2026 | Townson Sharon | Chief Scientific Officer | M Exercise | 3,000 | $6.14 | $18,420 |
| Jun 11, 2026 | Skvarka Jan | Director | A Award | 25,800 | Not measured | Not measured |
| Jun 11, 2026 | Blackwell Kimberly | Director | A Award | 25,800 | Not measured | Not measured |
| Jun 11, 2026 | Behbahani Ali | Director | A Award | 25,800 | Not measured | Not measured |
| Jun 11, 2026 | Hughes Eric A | Director | A Award | 25,800 | Not measured | Not measured |
| Jun 11, 2026 | Manning Anthony M. | Director | A Award | 25,800 | Not measured | Not measured |
| Jun 11, 2026 | SCHIFF ANDREW N | Director | A Award | 25,800 | Not measured | Not measured |
| Jun 11, 2026 | Siu Christine | Director | A Award | 25,800 | Not measured | Not measured |
| Jun 1, 2026 | Warmuth Markus | President & CEO | S Sale | 468 | $19.73 | $9,232 |
| Jun 1, 2026 | Warmuth Markus | President & CEO | S Sale | 4,998 | $19.41 | $97,021 |
| May 29, 2026 | Townson Sharon | Chief Scientific Officer | S Sale | 6,000 | $19.87 | $119,220 |
| May 29, 2026 | Townson Sharon | Chief Scientific Officer | M Exercise | 6,000 | $6.14 | $36,840 |
| May 29, 2026 | Townson Sharon | Chief Scientific Officer | M Exercise | 6,000 | Not measured | Not measured |
| May 27, 2026 | Champoux Jennifer | Chief Operating Officer | S Sale | 2,175 | $20.00 | $43,500 |
| May 27, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 2,175 | $3.98 | $8,657 |
| May 27, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 2,175 | Not measured | Not measured |
| May 22, 2026 | Champoux Jennifer | Chief Operating Officer | S Sale | 2,176 | $19.00 | $41,344 |
| May 22, 2026 | Champoux Jennifer | Chief Operating Officer | M Exercise | 2,176 | $3.98 | $8,660 |
The full Form 4 history is on the GLUE company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.